The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Health Catalyst Inc shares valued at $10,804 were sold by Llewelyn Linda on Oct 15 ’24. At $8.16 per share, Llewelyn Linda sold 1,324 shares. The insider’s holdings dropped to 114,275 shares worth approximately $0.89 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, LINDA LLEWELYN purchased 1,324 shares, netting a total of over 10,897 in proceeds.
Before that, LeSueur Daniel had sold 5,209 shares from its account. In a trade valued at $40,011, the Chief Operating Officer traded Health Catalyst Inc shares for $7.68 each. Upon closing the transaction, the insider’s holdings decreased to 5,209 shares, worth approximately $1.05 million.
As published in a research note from KeyBanc Capital Markets on April 10, 2024, Health Catalyst Inc [HCAT] has been rated down from an Overweight to a Sector weight. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in early January. As of January 03, 2024, Barclays has initiated its “an Overweight” rating for HCAT. Earlier on December 13, 2023, JP Morgan upgraded its rating. Their new recommendation was “an Overweight” for HCAT stock which previously was a “a Neutral”.
Analyzing HCAT Stock Performance
During the last five days, there has been a drop of approximately -10.06%. Over the course of the year, Health Catalyst Inc shares have dropped approximately -15.98%. Shares of the company reached a 52-week high of $11.41 on 01/12/24 and a 52-week low of $5.42 on 08/07/24. A 50-day SMA is recorded $7.85, while a 200-day SMA reached $7.56. Nevertheless, trading volume fell to 0.7 million shares from 0.55 million shares the previous day.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
According to the 24-hour chart, there is a support level at 7.63, which, if violated, would cause prices to drop to 7.48. In the upper region, resistance lies at 8.07. The next price resistance is at 8.36. RSI (Relative Strength Index) is 42.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.07, which suggests the price will decrease in the coming days. Percent R is at 79.29%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
